Results of Our Treatment Program for Stage 3 Chronic Kidney Disease Patients in CKD Clinic Bang Pa In Hospital

Abstract

Stage 3 Chronic Kidney Disease Patients are at high risk of complications caused by the dysfunctional organ. Such conditions often lead to premature death, as well as higher expenses for the healthcare provider. This only becomes more troublesome as the disease progresses into its final stage, where the patients require renal replacement therapy. In mitigating these effects, the CKD Clinic plays a crucial role in promoting behavioral changes in patients. To measure the effectiveness of this treatment program, 150 CKD Clinic patients are divided into two groups in a quasi-experimental research, using a simple questionnaire as a selection process. Throughout 12 weeks, one group received the standard treatment, while the other was treated with the new program. Tools used in the program include a guideline for stage 3 chronic kidney disease with a reliability index of 0.97, a set of quizzes on kidney disease with a reliability index of 0.74, and a survey on self-care behaviors to promote kidney health with a reliability index of 0.82. The results are reported in means, percentages, and standard deviation. Meanwhile, the pre- and post-research results are compared with paired samples test statistics and with t-test for independent sample statistics for inter-group comparisons. This research found that the experimental group has a significant increase (p<0.001) in kidney filtration rates, which are also significantly higher than those of the control group. Moreover, the experimental group is significantly (p<0.001) more knowledgeable about chronic kidney disease, significantly more so than the control group as well. Finally, the experimental group scores significantly higher (p<0.001) on assessments of behaviors that prevent kidney deterioration, and also significant higher than the control group. As such, the Treatment Program for Stage 3 Chronic Kidney Disease should be used and implemented for CKD clinics to improve the patients’ quality of life, allow patients to lead a normal life, and prevent the disease from progressing to the final stage.